Mineralisation defects after pamidronate for Paget's disease

Lancet. 1994 May 14;343(8907):1231-2. doi: 10.1016/s0140-6736(94)92446-5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Calcification, Physiologic / drug effects
  • Diphosphonates / adverse effects*
  • Humans
  • Hyperparathyroidism, Secondary / chemically induced
  • Osteitis Deformans / drug therapy*
  • Osteomalacia / chemically induced*
  • Pamidronate

Substances

  • Diphosphonates
  • Pamidronate